In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just small-molecule drugs—by illuminating how proteins fold and interact, all the ...

Vilya, a start-up based on the work of David Baker and other scientists at the University of Washington’s Institute for Protein Design, has launched with $50 mil- lion in series A financing. Vilya ...

De novo enzyme design has been used, primarily, in efforts to introduce active sites and substrate-binding pockets. Now, for the first time, scientists have used machine learning to create brand-new ...

MADISON, Wis.--(BUSINESS WIRE)--Leading advisory CPA firm Baker Tilly US, LLP (Baker Tilly) announces its state-of-the-art Innovation Lab and dynamic Innovation Ignite program. These initiatives ...

Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More A breakthrough in the science used to ...

For 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker ...